CNX
46
-2
KMB
48
-3
FE
46
-11
PRU
54
3
APD
37
-3
CCL
40
3
EMC
53
11
WU
48
-4
FOXA
52
2
EXC
69
-3
VMC
60
4
JNPR
58
2
JPM
55
2
REGN
36
-4
MRK
30
-3
MDLZ
55
-10
L
55
10
PCG
48
3
TXN
30
-5
SYF
55
7
CNX
46
-2
KMB
48
-3
FE
46
-11
PRU
54
3
APD
37
-3
CCL
40
3
EMC
53
11
WU
48
-4
FOXA
52
2
EXC
69
-3
VMC
60
4
JNPR
58
2
JPM
55
2
REGN
36
-4
MRK
30
-3
MDLZ
55
-10
L
55
10
PCG
48
3
TXN
30
-5
SYF
55
7
Financhill
Back

Thomson Reuters Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
44

TRI
Thomson Reuters

Last Price:
$170.36
Seasonality Move:
6.13%
Buy
54

DRUG
Bright Minds Biosciences

Last Price:
$35.92
Seasonality Move:
-28.52%
Sell
44
Thomson Reuters (TRI) is a Sell

Is Thomson Reuters a Buy, Sell or Hold?

  • The current Thomson Reuters [TRI] share price is $171.02. The Score for TRI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • TRI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Bright Minds Biosciences (DRUG) is a Buy

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $36.25. The Score for DRUG is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TRI Stock Price Chart

What is Thomson Reuters's stock price today?

  • The Thomson Reuters share price today is $171.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRI is experiencing slight selling pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $36.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.23 Buy
Relative Strength Index (14 RSI): 43.82 Sell
Chaikin Money Flow: -172333 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (172.04 - 178.54) Sell
Bollinger Bands (100): (161.24 - 173.16) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 50.3 Buy
Chaikin Money Flow: 47724 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.85 - 42.25) Sell
Bollinger Bands (100): (33.67 - 45.15) Sell

TRI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 175.56 Sell
20-day SMA: 176.11 Sell
50-day SMA: 168.51 Buy
200-day SMA: 167.25 Buy
8-day EMA: 174.53 Sell
20-day EMA: 174.4 Sell
50-day EMA: 171.1 Sell
200-day EMA: 164.98 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.16 Buy
20-day SMA: 37.2 Sell
50-day SMA: 37.07 Sell
200-day SMA: 20.27 Buy
8-day EMA: 35.28 Buy
20-day EMA: 36.12 Buy
50-day EMA: 36.52 Sell
200-day EMA: 24.96 Buy

Thomson Reuters Earnings Growth & TRI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.31 per share, an increase this year of $0.15 per share, and an increase next year of $0.52 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.85 per share, and a decrease next year of $2.17 per share.

Thomson Reuters Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):